A Leeman1, M Del Pino2, A Molijn1, A Rodriguez2, A Torné2, M de Koning1, J Ordi3, F van Kemenade4, D Jenkins1, W Quint1. 1. DDL Diagnostic Laboratory, ER Rijswijk, the Netherlands. 2. Faculty of Medicine-University 9 of Barcelona, Institute of Gynaecology, Obstetrics and Neonatology, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi I 8 Sunyer (IDIBAPS), Barcelona, Spain. 3. Department of Pathology, ISGLobal 11 (Institut de Salit Global de Barcelona)-Hospital Clínic, Barcelona, Spain. 4. Department of Pathology, Erasmus Medical Centre, CA Rotterdam, the Netherlands.
Abstract
OBJECTIVE: To compare the sensitivity of high-risk human papillomavirus (hrHPV) and genotype detection in self-collected urine samples in the morning (U1), and later on (U2), brush-based self-samples (SS), and clinician-taken smears (CTS) for detecting cervical intraepithelial neoplasia grade 2+ (CIN2+) in a colposcopic referral population. DESIGN: Cross-sectional single-centre study. SETTING: A colposcopy clinic in Spain. POPULATION: A cohort of 113 women referred for colposcopy after an abnormal Pap smear. METHODS: Women undergoing colposcopy with biopsy for abnormal Pap smears were sent a device (Colli-Pee™, Novosanis, Wijnegem, Belgium) to collect U1 on the morning of colposcopy. U2, CTS, and SS (Evalyn brush™, Rovers Medical Devices B.V., Oss, the Netherlands) were also analysed. All samples were tested for HPV DNA using the analytically sensitive SPF10-DEIA-LiPA25 assay and the clinically validated GP5+/6+-EIA-LMNX. MAIN OUTCOME MEASURES: Histologically confirmed CIN2+ and hrHPV positivity for 14 high-risk HPV types. RESULTS: Samples from 91 patients were analysed. All CIN3 cases (n = 6) tested positive for hrHPV in CTS, SS, U1, and U2 with both HPV assays. Sensitivity for CIN2+ with the SPF10 system was 100, 100, 95, and 100%, respectively. With the GP5+/6+ assay, sensitivity was 95% in all sample types. The sensitivities and specificities for both tests on each of the sample types did not significantly differ. There was 10-14% discordance on hrHPV genotype. CONCLUSIONS: CIN2+ detection using HPV testing of U1 shows a sensitivity similar to that of CTS or brush-based SS, and is convenient. There was substantial to almost excellent agreement between all samples on genotype with both hrHPV assays. There was no advantage in testing U1 compared with U2 samples. TWEETABLE ABSTRACT: Similar CIN2+ sensitivity for HPV testing in first-void urine, physician-taken smear and brush-based self-sample.
OBJECTIVE: To compare the sensitivity of high-risk human papillomavirus (hrHPV) and genotype detection in self-collected urine samples in the morning (U1), and later on (U2), brush-based self-samples (SS), and clinician-taken smears (CTS) for detecting cervical intraepithelial neoplasia grade 2+ (CIN2+) in a colposcopic referral population. DESIGN: Cross-sectional single-centre study. SETTING: A colposcopy clinic in Spain. POPULATION: A cohort of 113 women referred for colposcopy after an abnormal Pap smear. METHODS: Women undergoing colposcopy with biopsy for abnormal Pap smears were sent a device (Colli-Pee™, Novosanis, Wijnegem, Belgium) to collect U1 on the morning of colposcopy. U2, CTS, and SS (Evalyn brush™, Rovers Medical Devices B.V., Oss, the Netherlands) were also analysed. All samples were tested for HPV DNA using the analytically sensitive SPF10-DEIA-LiPA25 assay and the clinically validated GP5+/6+-EIA-LMNX. MAIN OUTCOME MEASURES: Histologically confirmed CIN2+ and hrHPV positivity for 14 high-risk HPV types. RESULTS: Samples from 91 patients were analysed. All CIN3 cases (n = 6) tested positive for hrHPV in CTS, SS, U1, and U2 with both HPV assays. Sensitivity for CIN2+ with the SPF10 system was 100, 100, 95, and 100%, respectively. With the GP5+/6+ assay, sensitivity was 95% in all sample types. The sensitivities and specificities for both tests on each of the sample types did not significantly differ. There was 10-14% discordance on hrHPV genotype. CONCLUSIONS: CIN2+ detection using HPV testing of U1 shows a sensitivity similar to that of CTS or brush-based SS, and is convenient. There was substantial to almost excellent agreement between all samples on genotype with both hrHPV assays. There was no advantage in testing U1 compared with U2 samples. TWEETABLE ABSTRACT: Similar CIN2+ sensitivity for HPV testing in first-void urine, physician-taken smear and brush-based self-sample.
Authors: Eliane Rohner; F Hunter McGuire; Yutong Liu; Quefeng Li; Kate Miele; Samveg A Desai; John W Schmitt; Andrea Knittel; Julie A E Nelson; Claire Edelman; Vijay Sivaraman; Anna Baker; LaHoma S Romocki; Lisa Rahangdale; Jennifer S Smith Journal: J Womens Health (Larchmt) Date: 2020-03-26 Impact factor: 2.681
Authors: Eliane Rohner; Lisa Rahangdale; Busola Sanusi; Andrea K Knittel; Laurence Vaughan; Kirsty Chesko; Brian Faherty; Samantha E Tulenko; John W Schmitt; LaHoma S Romocki; Vijay Sivaraman; Julie A E Nelson; Jennifer S Smith Journal: J Clin Microbiol Date: 2020-02-24 Impact factor: 5.948
Authors: Louise Cadman; Caroline Reuter; Mark Jitlal; Michelle Kleeman; Janet Austin; Tony Hollingworth; Anna L Parberry; Lesley Ashdown-Barr; Deepali Patel; Belinda Nedjai; Attila T Lorincz; Jack Cuzick Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-01-29 Impact factor: 4.254
Authors: Severien Van Keer; Annina P van Splunter; Jade Pattyn; Annemie De Smet; Sereina A Herzog; Xaveer Van Ostade; Wiebren A A Tjalma; Margareta Ieven; Pierre Van Damme; Renske D M Steenbergen; Alex Vorsters Journal: Sci Rep Date: 2021-04-12 Impact factor: 4.379
Authors: Rubí Hernández-López; Luis Hermosillo; Leith León-Maldonado; Rafael Velázquez-Cruz; Leticia Torres-Ibarra; Eduardo Lazcano-Ponce; Attila Lörincz; Cosette M Wheeler; F Xavier Bosch; Jack Cuzick; Berenice Rivera-Paredez; Belinda Nedjai; Jorge Salmerón Journal: PLoS One Date: 2021-07-21 Impact factor: 3.240
Authors: Rianne van den Helder; Nienke E van Trommel; Annina P van Splunter; Birgit I Lissenberg-Witte; Maaike C G Bleeker; Renske D M Steenbergen Journal: Papillomavirus Res Date: 2020-03-13